Hluboké učení pro lokalizaci epileptického ložiska

Abstract

Epilepsy affects about 50 million people worldwide, with one-third of patients being drugresistant and therefore candidates for an invasive brain resection surgery. Brain resection surgery candidates undergo invasive intracranial encephalography (iEEG) monitoring to determine the seizure onset zone (SOZ). Recorded data can span over weeks and need to be manually reviewed by a physician to assess SOZ. This process can be time-consuming and burdensome due to the vast amount of collected data. This work investigates utilisation of an deep autoencoder for unsupervised data exploration and specifically its ability to discriminate between SOZ and non-SOZ (NSOZ) iEEG channels. The data used in this thesis consists of iEEG collected from 33 patients in two institutes (Mayo Clinic, Rochester, Minnesota, USA and St. Anne´s University Hospital, Brno, Czech Republic - FNUSA) who underwent invasive presurgical monitoring. The autoencoder’s capability to discriminate between SOZ and NSOZ was evaluated using a self-learned embedded feature space representation of the autoencoder network. Autoencoder features were compared to previously established biomarkers for SOZ determination. Discrimination capability was evaluated for both autoencoder features and biomarkers using a Naive Bayes classifier and leave-one-out cross-validation. The achieved area under receiver operating characteristic curve (AUROC) was 0.68 for the FNUSA and 0.56 for the Mayo dataset. Performance in discriminating between SOZ and NSOZ electrodes was not significantly different between the investigated autoencoder features and previously established biomarkers. Selecting the better performing classifier for each patient increased the AUROC to 0.75 and 0.64 for the FNUSA and Mayo dataset, respectively. The results suggest that future approaches combining biomarkers and self-learning methods have a potential to improve the SOZ vs NSOZ discrimination capability of unsupervised iEEG exploration systems, and thus to enhance the surgical management of epilepsy.Epilepsy affects about 50 million people worldwide, with one-third of patients being drugresistant and therefore candidates for an invasive brain resection surgery. Brain resection surgery candidates undergo invasive intracranial encephalography (iEEG) monitoring to determine the seizure onset zone (SOZ). Recorded data can span over weeks and need to be manually reviewed by a physician to assess SOZ. This process can be time-consuming and burdensome due to the vast amount of collected data. This work investigates utilisation of an deep autoencoder for unsupervised data exploration and specifically its ability to discriminate between SOZ and non-SOZ (NSOZ) iEEG channels. The data used in this thesis consists of iEEG collected from 33 patients in two institutes (Mayo Clinic, Rochester, Minnesota, USA and St. Anne´s University Hospital, Brno, Czech Republic - FNUSA) who underwent invasive presurgical monitoring. The autoencoder’s capability to discriminate between SOZ and NSOZ was evaluated using a self-learned embedded feature space representation of the autoencoder network. Autoencoder features were compared to previously established biomarkers for SOZ determination. Discrimination capability was evaluated for both autoencoder features and biomarkers using a Naive Bayes classifier and leave-one-out cross-validation. The achieved area under receiver operating characteristic curve (AUROC) was 0.68 for the FNUSA and 0.56 for the Mayo dataset. Performance in discriminating between SOZ and NSOZ electrodes was not significantly different between the investigated autoencoder features and previously established biomarkers. Selecting the better performing classifier for each patient increased the AUROC to 0.75 and 0.64 for the FNUSA and Mayo dataset, respectively. The results suggest that future approaches combining biomarkers and self-learning methods have a potential to improve the SOZ vs NSOZ discrimination capability of unsupervised iEEG exploration systems, and thus to enhance the surgical management of epilepsy.